Caris Life Sciences, a US-based molecular science and technology company, announced on Friday that it has named Lloyd B. Minor, M.D as its new director effective immediately.
Dr Minor holds the position of Carl and Elizabeth Naumann dean at the Stanford University School of Medicine. He has served as the provost and senior vice president for academic affairs of The Johns Hopkins University. He was elected to the National Academy of Medicine, formerly the Institute of Medicine in 2012.
David D. Halbert, Caris Life Sciences chairman and CEO, said, 'We are excited to welcome Dr. Minor to the Caris Board. Dr Minor's combined expertise in academia and science has established him as a leading advocate for innovation in the field of precision healthcare and his perspectives will be invaluable as we reinvent the way medicine is practiced, and pursue our vision to improve patient outcomes across all disease types worldwide.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer